Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Oslo University Hospital
With
University of Oslo
The FARP randomized control study will compare focal ablation of prostate using High Intensity Focused Ultrasound (HIFU) applied by FocalOne® or TULSA® device versus Radical Prostatectomy (RP) in patients with unilateral, intermediate risk prostate cancer.
Age
45–80
Sex
MALE
Healthy volunteers
Not accepted
You may not be if
PSA ≤ 20 ng/ml
Treatment naive patients with localized prostate cancer (stage ≤ T2b)
Clinical stage T\> 2b
Metastatic lymph node on imaging
Patients already treated for Pca (hormone therapy, EBRT)
Patients with contra-indications to MRI
Patients with active inflammatory bowel disease or previous rectal fistula
History of previous pelvic radiotherapy
History of bladder cancer
History of bladder neck or urethral stricture
Urogenital infection in progress
Allergy to latex or gadolinium
Patients on life support or suffering form unstable neurological diseases
Clareo Health | Focal Prostate Ablation Versus Radical Prostatectomy
